OpenURL Connection Search

Select item for more details and to access through your institution.

Sclerosing mesenteritis following immune checkpoint inhibitor therapy.
Published in:
Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 11, p. 9221, doi. 10.1007/s00432-023-04802-2
By:
- Kuang, Andrew G.;
- Sperling, Gabriel;
- Liang, Tom Z.;
- Lu, Yang;
- Tan, Dongfeng;
- Bollin, Kathryn;
- Johnson, Douglas B.;
- Manzano, Joanna-Grace M.;
- Shatila, Malek;
- Thomas, Anusha S.;
- Thompson, John A.;
- Zhang, Hao Chi;
- Wang, Yinghong
Publication type:
Article
Challenging Dermatologic Considerations Associated with Immune Checkpoint Inhibitors.
Published in:
American Journal of Clinical Dermatology, 2022, v. 23, n. 5, p. 707, doi. 10.1007/s40257-022-00706-y
By:
- Park, Benjamin C.;
- Jung, Seungyeon;
- Chen, Steven T.;
- Dewan, Anna K.;
- Johnson, Douglas B.
Publication type:
Article
Combinatorial Therapies in Melanoma: MAPK Inhibitors and Beyond.
Published in:
American Journal of Clinical Dermatology, 2018, v. 19, n. 2, p. 181, doi. 10.1007/s40257-017-0320-y
By:
- Zhou, Alice Y.;
- Johnson, Douglas B.
Publication type:
Article
Immunotherapy in Older Adults with Cancer.
Published in:
Current Oncology Reports, 2019, v. 21, n. 7, p. 1, doi. 10.1007/s11912-019-0806-2
By:
- Godby, Richard Curtis;
- Johnson, Douglas B.;
- Williams, Grant R.
Publication type:
Article
Molecular Targeted Therapy Approaches for BRAF Wild-Type Melanoma.
Published in:
Current Oncology Reports, 2016, v. 18, n. 1, p. 1, doi. 10.1007/s11912-015-0485-6
By:
- Johnpulle, Romany A. N.;
- Johnson, Douglas B.;
- Sosman, Jeffrey A.
Publication type:
Article
Approach to the Patient With Immune Checkpoint Inhibitor--Associated Endocrine Dysfunction.
Published in:
Journal of Clinical Endocrinology & Metabolism, 2023, v. 108, n. 6, p. 1514, doi. 10.1210/clinem/dgac689
By:
- Wright, Jordan J.;
- Johnson, Douglas B.
Publication type:
Article
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-mediated cardiovascular, rheumatic, and renal toxicities from checkpoint inhibitors.
Published in:
Supportive Care in Cancer, 2020, v. 28, n. 12, p. 6159, doi. 10.1007/s00520-020-05710-8
By:
- Suarez-Almazor, Maria E.;
- Pundole, Xerxes;
- Abdel-Wahab, Noha;
- Johnson, Douglas B.;
- Gupta, Dipti;
- Glezerman, Ilya;
- Cooksley, Tim;
- Anderson, Ronald;
- Blidner, Ada;
- Choi, Jennifer;
- Dougan, Michael;
- Ginex, Pamela;
- Girotra, Monica;
- Shannon, Vickie R.;
- Rapoport, Bernardo L.
Publication type:
Article
MASCC 2020 recommendations for the management of immune-related adverse events of patients undergoing treatment with immune checkpoint inhibitors.
Published in:
2020
By:
- Rapoport, Bernardo L.;
- Anderson, Ronald;
- Cooksley, Tim;
- Johnson, Douglas B.
Publication type:
Editorial
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-related adverse events: pulmonary toxicity.
Published in:
Supportive Care in Cancer, 2020, v. 28, n. 12, p. 6145, doi. 10.1007/s00520-020-05708-2
By:
- Shannon, Vickie R.;
- Anderson, Ronald;
- Blidner, Ada;
- Choi, Jennifer;
- Cooksley, Tim;
- Dougan, Michael;
- Glezerman, Ilya;
- Ginex, Pamela;
- Girotra, Monica;
- Gupta, Dipti;
- Johnson, Douglas B.;
- Suarez-Almazor, Maria E.;
- Rapoport, Bernardo L.
Publication type:
Article
Impact of Patient Age on Clinical Efficacy and Toxicity of Checkpoint Inhibitor Therapy.
Published in:
Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.786046
By:
- Wong, Selina K.;
- Nebhan, Caroline A.;
- Johnson, Douglas B.
Publication type:
Article
Targeting wild-type TP53 using AMG 232 in combination with MAPK inhibition in Metastatic Melanoma; a phase 1 study.
Published in:
Investigational New Drugs, 2022, v. 40, n. 5, p. 1051, doi. 10.1007/s10637-022-01253-3
By:
- Moschos, Stergios J.;
- Sandhu, Shahneen;
- Lewis, Karl D.;
- Sullivan, Ryan J.;
- Puzanov, Igor;
- Johnson, Douglas B.;
- Henary, Haby A.;
- Wong, Hansen;
- Upreti, Vijay V.;
- Long, Georgina V.;
- Flaherty, Keith T.
Publication type:
Article
Pulmonary Toxicities Associated With the Use of Immune Checkpoint Inhibitors: An Update From the Immuno-Oncology Subgroup of the Neutropenia, Infection & Myelosuppression Study Group of the Multinational Association for Supportive Care in Cancer.
Published in:
Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.743582
By:
- Rapoport, Bernardo L.;
- Shannon, Vickie R.;
- Cooksley, Tim;
- Johnson, Douglas B.;
- Anderson, Lindsay;
- Blidner, Ada G.;
- Tintinger, Gregory R.;
- Anderson, Ronald
Publication type:
Article
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis.
Published in:
Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-023-44512-4
By:
- Middha, Pooja;
- Thummalapalli, Rohit;
- Betti, Michael J.;
- Yao, Lydia;
- Quandt, Zoe;
- Balaratnam, Karmugi;
- Bejan, Cosmin A.;
- Cardenas, Eduardo;
- Falcon, Christina J.;
- Faleck, David M.;
- Leighl, Natasha B.;
- Bradbury, Penelope A.;
- Shepherd, Frances A.;
- Sacher, Adrian G.;
- Eng, Lawson;
- Gubens, Matthew A.;
- Huntsman, Scott;
- Johnson, Douglas B.;
- Kachuri, Linda;
- Khan, Khaleeq
Publication type:
Article
Margin-Negative en Bloc Resection of a Large Retroperitoneal Melanoma Including Reconstruction of the Infra-renal Inferior Vena Cava.
Published in:
American Surgeon, 2023, v. 89, n. 8, p. 3668, doi. 10.1177/00031348231173956
By:
- Slutsky, Hanna L.;
- Johnson, Douglas B.;
- Stone, Patrick;
- Tan, Marcus C. B.
Publication type:
Article
Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade.
Published in:
Molecular Cancer, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12943-021-01366-y
By:
- Yan, Chi;
- Saleh, Nabil;
- Yang, Jinming;
- Nebhan, Caroline A.;
- Vilgelm, Anna E.;
- Reddy, E. Premkumar;
- Roland, Joseph T.;
- Johnson, Douglas B.;
- Chen, Sheau-Chiann;
- Shattuck-Brandt, Rebecca L.;
- Ayers, Gregory D.;
- Richmond, Ann
Publication type:
Article
Immune Checkpoint Inhibitor Therapy in Patients With Autoimmune Disease.
Published in:
Oncology (08909091), 2018, v. 32, n. 4, p. 190
By:
- Johnson, Douglas B.;
- Beckermann, Kathryn E.;
- Wang, Daniel Y.
Publication type:
Article
Combination Immunotherapy: An Emerging Paradigm in Cancer Therapeutics.
Published in:
Oncology (08909091), 2015, v. 29, n. 12, p. 1005
By:
- Wang, Daniel Y.;
- Sosman, Jeffrey A.;
- Johnson, Douglas B.
Publication type:
Article
Evolving insights into the mechanisms of toxicity associated with immune checkpoint inhibitor therapy.
Published in:
British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1778, doi. 10.1111/bcp.14433
By:
- Mangan, Brendan L.;
- McAlister, Renee K.;
- Balko, Justin M.;
- Johnson, Douglas B.;
- Moslehi, Javid J.;
- Gibson, Andrew;
- Phillips, Elizabeth J.
Publication type:
Article
Primary Tumor Characteristics as Biomarkers of Immunotherapy Response in Advanced Melanoma: A Retrospective Cohort Study.
Published in:
Cancers, 2024, v. 16, n. 13, p. 2355, doi. 10.3390/cancers16132355
By:
- Goodman, Rachel S.;
- Jung, Seungyeon;
- Fletcher, Kylie;
- Burnette, Hannah;
- Mohyuddin, Ismail;
- Irlmeier, Rebecca;
- Ye, Fei;
- Johnson, Douglas B.
Publication type:
Article
Incidence of Cutaneous Immune-Related Adverse Events and Outcomes in Immune Checkpoint Inhibitor-Containing Regimens: A Systematic Review and Meta-Analysis.
Published in:
Cancers, 2024, v. 16, n. 2, p. 340, doi. 10.3390/cancers16020340
By:
- Curkovic, Nina B.;
- Bai, Kun;
- Ye, Fei;
- Johnson, Douglas B.
Publication type:
Article
Characterization of Age-Associated, Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammatory Index (SII) as Biomarkers of Inflammation in Geriatric Patients with Cancer Treated with Immune Checkpoint Inhibitors: Impact on Efficacy and Survival
Published in:
Cancers, 2023, v. 15, n. 20, p. 5052, doi. 10.3390/cancers15205052
By:
- Choucair, Khalil;
- Nebhan, Caroline;
- Cortellini, Alessio;
- Hentzen, Stijn;
- Wang, Yinghong;
- Liu, Cynthia;
- Giusti, Raffaele;
- Filetti, Marco;
- Ascierto, Paolo Antonio;
- Vanella, Vito;
- Galetta, Domenico;
- Catino, Annamaria;
- Al-Bzour, Nour;
- Saeed, Azhar;
- Cavalcante, Ludimila;
- Pizzutilo, Pamela;
- Genova, Carlo;
- Bersanelli, Melissa;
- Buti, Sebastiano;
- Johnson, Douglas B.
Publication type:
Article
Cardiovascular toxicities associated with immune checkpoint inhibitors.
Published in:
Cardiovascular Research, 2019, v. 115, n. 5, p. 854, doi. 10.1093/cvr/cvz026
By:
- Hu, Jiun-Ruey;
- Florido, Roberta;
- Lipson, Evan J;
- Naidoo, Jarushka;
- Ardehali, Reza;
- Tocchetti, Carlo G;
- Lyon, Alexander R;
- Padera, Robert F;
- Johnson, Douglas B;
- Moslehi, Javid
Publication type:
Article
Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma.
Published in:
BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10708-6
By:
- Johnson, Douglas B.;
- Atkins, Michael B.;
- Hennessy, Cassandra;
- Wise-Draper, Trisha;
- Heilman, Hannah;
- Awosika, Joy;
- Bakouny, Ziad;
- Labaki, Chris;
- Saliby, Renee Maria;
- Hwang, Clara;
- Singh, Sunny R. K.;
- Balanchivadze, Nino;
- Friese, Christopher R.;
- Fecher, Leslie A.;
- Yoon, James J.;
- Hayes-Lattin, Brandon;
- Bilen, Mehmet A.;
- Castellano, Cecilia A.;
- Lyman, Gary H.;
- Tachiki, Lisa
Publication type:
Article
Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade.
Published in:
Molecular Cancer, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12943-021-01366-y
By:
- Chi Yan;
- Nabil Saleh;
- Jinming Yang;
- Nebhan, Caroline A.;
- Vilgelm, Anna E.;
- Reddy, E. Premkumar;
- Roland, Joseph T.;
- Johnson, Douglas B.;
- Sheau-Chiann Chen;
- Shattuck-Brandt, Rebecca L.;
- Ayers, Gregory D.;
- Richmond, Ann
Publication type:
Article
Extended Follow-Up of Chronic Immune-Related Adverse Events Following Adjuvant Anti–PD-1 Therapy for High-Risk Resected Melanoma.
Published in:
JAMA Network Open, 2023, v. 6, n. 8, p. e2327145, doi. 10.1001/jamanetworkopen.2023.27145
By:
- Goodman, Rachel S.;
- Lawless, Aleigha;
- Woodford, Rachel;
- Fa'ak, Faisal;
- Tipirneni, Asha;
- Patrinely, J. Randall;
- Yeoh, Hui Ling;
- Rapisuwon, Suthee;
- Haydon, Andrew;
- Osman, Iman;
- Mehnert, Janice M.;
- Long, Georgina V.;
- Sullivan, Ryan J.;
- Carlino, Matteo S.;
- Menzies, Alexander M.;
- Johnson, Douglas B.
Publication type:
Article
Biomarkers of immune checkpoint inhibitor response and toxicity: Challenges and opportunities.
Published in:
Immunological Reviews, 2023, v. 318, n. 1, p. 157, doi. 10.1111/imr.13249
By:
- Goodman, Rachel S.;
- Jung, Seungyeon;
- Balko, Justin M.;
- Johnson, Douglas B.
Publication type:
Article
Pragmatic precision oncology: the secondary uses of clinical tumor molecular profiling.
Published in:
2016
By:
- Rioth, Matthew J.;
- Thota, Ramya;
- Staggs, David B.;
- Johnson, Douglas B.;
- Warner, Jeremy L.
Publication type:
journal article
Continued Poor Survival in Metastatic Uveal Melanoma: Implications for Molecular Prognostication, Surveillance Imaging, Adjuvant Therapy, and Clinical Trials.
Published in:
2018
By:
- Johnson, Douglas B.;
- Daniels, Anthony B.
Publication type:
journal article
Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition — A Descriptive Observational Retrospective Multicenter Analysis.
Published in:
Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.765608
By:
- Zaremba, Anne;
- Kramer, Rafaela;
- De Temple, Viola;
- Bertram, Stefanie;
- Salzmann, Martin;
- Gesierich, Anja;
- Reinhardt, Lydia;
- Baroudjian, Barouyr;
- Sachse, Michael M.;
- Mechtersheimer, Gunhild;
- Johnson, Douglas B.;
- Weppler, Alison M.;
- Spain, Lavinia;
- Loquai, Carmen;
- Dudda, Milena;
- Pföhler, Claudia;
- Hepner, Adriana;
- Long, Georgina V.;
- Menzies, Alexander M.;
- Carlino, Matteo S.
Publication type:
Article
Nivolumab in melanoma: latest evidence and clinical potential.
Published in:
Therapeutic Advances in Medical Oncology, 2015, v. 7, n. 2, p. 97, doi. 10.1177/1758834014567469
By:
- Johnson, Douglas B.;
- Peng, Chengwei;
- Sosman, Jeffrey A.
Publication type:
Article
Antibody-Drug Conjugates for Melanoma and Other Skin Malignancies.
Published in:
Current Treatment Options in Oncology, 2022, v. 23, n. 10, p. 1428, doi. 10.1007/s11864-022-01018-3
By:
- Goodman, Rachel;
- Johnson, Douglas B.
Publication type:
Article
Defining and Targeting BRAF Mutations in Solid Tumors.
Published in:
2021
By:
- Halle, Briana R.;
- Johnson, Douglas B.
Publication type:
journal article
Management of V600E and V600K BRAF-Mutant Melanoma.
Published in:
2019
By:
- Haugh, Alexandra M.;
- Johnson, Douglas B.
Publication type:
journal article
Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge (Naples, November 30th–December 1st, 2022).
Published in:
Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04117-3
By:
- Ascierto, Paolo A.;
- Avallone, Antonio;
- Bifulco, Carlo;
- Bracarda, Sergio;
- Brody, Joshua D.;
- Emens, Leisha A.;
- Ferris, Robert L.;
- Formenti, Silvia C.;
- Hamid, Omid;
- Johnson, Douglas B.;
- Kirchhoff, Tomas;
- Klebanoff, Christopher A.;
- Lesinski, Gregory B.;
- Monette, Anne;
- Neyns, Bart;
- Odunsi, Kunle;
- Paulos, Chrystal M.;
- Powell Jr., Daniel J.;
- Rezvani, Katayoun;
- Segal, Brahm H.
Publication type:
Article
The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanoma.
Published in:
2022
By:
- Karachaliou, Georgia Sofia;
- Alkallas, Rached;
- Carroll, Sarah B.;
- Caressi, Chongshan;
- Zakria, Danny;
- Patel, Nirali M.;
- Trembath, Dimitri G.;
- Ezzell, Jennifer A.;
- Pegna, Guillaume J.;
- Googe, Paul B.;
- Galeotti, Jonathan P.;
- Ayvali, Fatih;
- Collichio, Frances A.;
- Lee, Carrie B.;
- Ollila, David W.;
- Gulley, Margaret L.;
- Johnson, Douglas B.;
- Kim, Kevin B.;
- Watson, Ian R.;
- Moschos, Stergios J.
Publication type:
journal article
A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti-PD-1 immunotherapy.
Published in:
2020
By:
- Theivanthiran, Balamayoora;
- Evans, Kathy S.;
- DeVito, Nicholas C.;
- Plebanek, Michael;
- Sturdivant, Michael;
- Wachsmuth, Luke P.;
- Salama, April K. S.;
- Yubin Kang;
- Hsu, David;
- Balko, Justin M.;
- Johnson, Douglas B.;
- Starr, Mark;
- Nixon, Andrew;
- Holtzhausen, Alisha;
- Hanks, Brent A.;
- Theivanthiran, Balamayooran;
- Plebanek, Michael P;
- Wachsmuth, Lucas P;
- Salama, April Ks;
- Kang, Yubin
Publication type:
journal article
Adult Neuroblastoma Complicated by Increased Intracranial Pressure: A Case Report and Review of the Literature.
Published in:
2014
By:
- Stevens, Patrick L.;
- Johnson, Douglas B.;
- Thompson, Mary Ann;
- Keedy, Vicki L.;
- Frangoul, Haydar A.;
- Snyder, Kristen M.
Publication type:
Case Study
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy.
Published in:
Nature Communications, 2016, v. 7, n. 1, p. 10582, doi. 10.1038/ncomms10582
By:
- Johnson, Douglas B.;
- Estrada, Monica V.;
- Salgado, Roberto;
- Sanchez, Violeta;
- Doxie, Deon B.;
- Opalenik, Susan R.;
- Vilgelm, Anna E.;
- Feld, Emily;
- Johnson, Adam S.;
- Greenplate, Allison R.;
- Sanders, Melinda E.;
- Lovly, Christine M.;
- Frederick, Dennie T.;
- Kelley, Mark C.;
- Richmond, Ann;
- Irish, Jonathan M.;
- Shyr, Yu;
- Sullivan, Ryan J.;
- Puzanov, Igor;
- Sosman, Jeffrey A.
Publication type:
Article
MDM2 antagonists overcome intrinsic resistance to CDK4/6 inhibition by inducing p21.
Published in:
Science Translational Medicine, 2019, v. 11, n. 505, p. 1, doi. 10.1126/scitranslmed.aav7171
By:
- Vilgelm, Anna E.;
- Saleh, Nabil;
- Shattuck-Brandt, Rebecca;
- Riemenschneider, Kelsie;
- Slesur, Lauren;
- Chen, Sheau-Chiann;
- Johnson, C. Andrew;
- Yang, Jinming;
- Blevins, Ashlyn;
- Yan, Chi;
- Johnson, Douglas B.;
- Al-Rohil, Rami N.;
- Halilovic, Ensar;
- Kauffmann, Rondi M.;
- Kelley, Mark;
- Ayers, Gregory D.;
- Richmond, Ann
Publication type:
Article
Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 8, p. 523, doi. 10.1016/j.clml.2024.03.011
By:
- Lurain, Kathryn;
- Zarif, Talal El;
- Ramaswami, Ramya;
- Nassar, Amin H.;
- Adib, Elio;
- Abdel-Wahab, Noha;
- Chintapally, Nikita;
- Drolen, Claire E.;
- Feldman, Tatyana;
- Haykal, Tarek;
- Nebhan, Caroline A.;
- Kambhampati, Swetha;
- Li, Mingjia;
- Mittra, Arjun;
- Lorentsen, Michael;
- Kim, Chul;
- Drakaki, Alexandra;
- Morse, Michael;
- Johnson, Douglas B.;
- Mangla, Ankit
Publication type:
Article
Correlates of response and outcomes with talimogene laherperpvec.
Published in:
Journal of Surgical Oncology, 2019, v. 120, n. 3, p. 558, doi. 10.1002/jso.25601
By:
- Zhou, Alice Y.;
- Wang, Daniel Y.;
- McKee, Svetlana;
- Ye, Fei;
- Wen, Chun‐Che;
- Wallace, Debbie E.;
- Ancell, Kristin K.;
- Conry, Robert M.;
- Johnson, Douglas B.
Publication type:
Article
Adverse Events Associated With Immune Checkpoint Inhibitors-Reply.
Published in:
2019
By:
- Johnson, Douglas B.;
- Chandra, Sunandana;
- Sosman, Jeffrey A.
Publication type:
Letter
Immune Checkpoint Inhibitor Toxicity in 2018.
Published in:
2018
By:
- Johnson, Douglas B.;
- Chandra, Sunandana;
- Sosman, Jeffrey A.
Publication type:
journal article
Breakthrough concepts in immune‐oncology: Cancer vaccines at the bedside.
Published in:
Journal of Leukocyte Biology, 2020, v. 108, n. 4, p. 1455, doi. 10.1002/JLB.5BT0420-585RR
By:
- Roy, Sohini;
- Sethi, Tarsheen K.;
- Taylor, David;
- Kim, Young J.;
- Johnson, Douglas B.
Publication type:
Article
Mass cytometry deep phenotyping of human mononuclear phagocytes and myeloid‐derived suppressor cells from human blood and bone marrow.
Published in:
Journal of Leukocyte Biology, 2017, v. 102, n. 2, p. 437, doi. 10.1189/jlb.5MA1116-457R
By:
- Roussel, Mikael;
- Ferrell, P. Brent;
- Greenplate, Allison R.;
- Lhomme, Faustine;
- Le Gallou, Simon;
- Diggins, Kirsten E.;
- Johnson, Douglas B.;
- Irish, Jonathan M.
Publication type:
Article
Clinical and genomic correlates of imatinib response in melanomas with KIT alterations.
Published in:
2022
By:
- Jung, Seungyeon;
- Armstrong, Emma;
- Wei, Alexander Z.;
- Ye, Fei;
- Lee, Aaron;
- Carlino, Matteo S.;
- Sullivan, Ryan J.;
- Carvajal, Richard D.;
- Shoushtari, Alexander N.;
- Johnson, Douglas B.
Publication type:
journal article
Clinical and laboratory features of autoimmune hemolytic anemia associated with immune checkpoint inhibitors.
Published in:
American Journal of Hematology, 2019, v. 94, n. 5, p. 563, doi. 10.1002/ajh.25448
By:
- Leaf, Rebecca Karp;
- Ferreri, Christopher;
- Rangachari, Deepa;
- Mier, James;
- Witteles, Wesley;
- Ansstas, George;
- Anagnostou, Theodora;
- Zubiri, Leyre;
- Piotrowska, Zofia;
- Oo, Thein H.;
- Iberri, David;
- Yarchoan, Mark;
- Salama, April K. S.;
- Johnson, Douglas B.;
- Leavitt, Andrew D.;
- Rahma, Osama E.;
- Reynolds, Kerry L.;
- Leaf, David E.
Publication type:
Article
Proximity of immune and tumor cells underlies response to BRAF/MEK-targeted therapies in metastatic melanoma patients.
Published in:
NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-021-00249-1
By:
- Yan, Chi;
- Chen, Sheau-Chiann;
- Ayers, Gregory D.;
- Nebhan, Caroline A.;
- Roland, Joseph T.;
- Weiss, Vivian L.;
- Johnson, Douglas B.;
- Richmond, Ann
Publication type:
Article
Health care utilization and steroid-refractory toxicities from immune checkpoint inhibitors.
Published in:
2020
By:
- Wang, Laura X.;
- Quach, Henry T.;
- Moodabigil, Nikil V.;
- Davis, Elizabeth J.;
- Sosman, Jeffrey A.;
- Dusetzina, Stacie B.;
- Johnson, Douglas B.
Publication type:
journal article
A phase 2 study of glembatumumab vedotin, an antibody-drug conjugate targeting glycoprotein NMB, in patients with advanced melanoma.
Published in:
2019
By:
- Ott, Patrick A.;
- Pavlick, Anna C.;
- Johnson, Douglas B.;
- Hart, Lowell L.;
- Infante, Jeffrey R.;
- Luke, Jason J.;
- Lutzky, Jose;
- Rothschild, Neal E.;
- Spitler, Lynn E.;
- Cowey, C. Lance;
- Alizadeh, Aaron R.;
- Salama, April K.;
- He, Yi;
- Hawthorne, Thomas R.;
- Bagley, Rebecca G.;
- Zhang, Joshua;
- Turner, Christopher D.;
- Hamid, Omid
Publication type:
journal article

Found: 80